Comparison between Bansal Wire Industries IPO and Emcure Pharmaceuticals IPO.
Bansal Wire Industries IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Emcure Pharmaceuticals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Bansal Wire Industries IPO is up to ₹745.00 Cr whereas the issue size of the Emcure Pharmaceuticals IPO is up to ₹1,952.03 Cr. The final issue price of Bansal Wire Industries IPO is ₹256.00 per share and of Emcure Pharmaceuticals IPO is ₹1,008.00 per share.
| Bansal Wire Industries IPO | Emcure Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹10 per share |
| Issue Price (Lower) | ₹243.00 per share | ₹960.00 per share |
| Issue Price (Upper) | ₹256.00 per share | ₹1,008.00 per share |
| Issue Price (Final) | ₹256.00 per share | ₹1,008.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹90.00 per share | |
| Market Lot Size | 58 shares | 14 shares |
| Fresh Issue Size | 2,91,01,562 shares | 79,46,231 shares |
| Fresh Issue Size (Amount) | up to ₹745.00 Cr | up to ₹800.58 Cr |
| OFS Issue Size | 0 shares | 1,14,28,839 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹1,151.45 Cr |
| Issue Size Total | 2,91,01,562 shares | 1,93,75,070 shares |
| Issue Size Total (Amount) | up to ₹745.00 Cr | up to ₹1,952.03 Cr |
Bansal Wire Industries IPO opens on Jul 03, 2024, while Emcure Pharmaceuticals IPO opens on Jul 03, 2024. The closing date of Bansal Wire Industries IPO and Emcure Pharmaceuticals IPO is Jul 05, 2024, and Jul 05, 2024, respectively.
| Bansal Wire Industries IPO | Emcure Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | Jul 02, 2024 | Jul 02, 2024 |
| Issue Open | Jul 03, 2024 | Jul 03, 2024 |
| Issue Close | Jul 05, 2024 | Jul 05, 2024 |
| Basis Of Allotment (Tentative) | Jul 08, 2024 | Jul 08, 2024 |
| Initiation of Refunds (Tentative) | Jul 09, 2024 | Jul 09, 2024 |
| Credit of Share (Tentative) | Jul 09, 2024 | Jul 09, 2024 |
| Listing date (Tentative) | Jul 10, 2024 | Jul 10, 2024 |
| Anchor Lockin End date 1 | Aug 07, 2024 | Aug 07, 2024 |
| Anchor Lockin End date 2 | Oct 06, 2024 | Oct 06, 2024 |
Bansal Wire Industries IPO P/E ratio is 41.41, as compared to Emcure Pharmaceuticals IPO P/E ratio of 34.55.
| Bansal Wire Industries IPO | Emcure Pharmaceuticals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 95.78 | 83.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 77.97 | 78.08 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 41.41 | 34.55 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹4007.83 Cr. | ₹19029.89 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 21.19% | 16.90% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 18.46% | 19.37% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.48 | 0.67 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.18 | ₹29.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 18.27% | 16.87% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Bansal Wire Industries IPO Retail Individual Investors (RII) are offered 1,01,85,547 shares while in Emcure Pharmaceuticals IPO retail investors are offered 1,01,85,547 shares. Qualified Institutional Buyers (QIB) are offered 58,20,312 shares in Bansal Wire Industries IPO and 38,53,234 shares in Emcure Pharmaceuticals IPO.
| Bansal Wire Industries IPO | Emcure Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | 87,30,468 shares | 57,79,850 shares |
| Market Maker Reservation | ||
| QIB | 58,20,312 shares | 38,53,234 shares |
| NII | 43,65,235 shares | 28,89,926 shares |
| RII | 1,01,85,547 shares | 67,43,160 shares |
| Employee | 1,08,900 shares | |
| Others | ||
| Total | 2,91,01,562 shares | 1,93,75,070 shares |
Bansal Wire Industries IPO subscribed 62.76x in total, whereas Emcure Pharmaceuticals IPO subscribed 67.87x.
| Bansal Wire Industries IPO | Emcure Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 153.86x | 191.24x |
| NII (times) | 54.21x | 49.32x |
| Big NII (times) | 55.27x | 54.90x |
| Small NII (times) | 52.11x | 38.16x |
| RII (times) | 14.37x | 7.36x |
| Employee (times) | 8.81x | |
| Other (times) | ||
| Total (times) | 62.76x | 67.87x |
